Many of your patients struggle to maintain good glycemic control, despite their best intentions. Whether your patient has type 1 or type 2 diabetes, or they are being treated with an insulin injection regimen or pump therapy – they may benefit from CGM.
Who Can Benefit from CGM?
The Dexcom G4® PLATINUM Professional CGM System is practice-owned and gives you real-time feedback and insights about your patient’s glycemic control, which can inform therapeutic treatment recommendations. The System can be blinded when clinically necessary.
CGM can benefit all patients taking insulin – whether they’re taking multiple daily insulin injections or using a pump.
Dexcom will be your trusted partner in bringing CGM to your practice and patients. We assist with patient onboarding, including verification of insurance coverage, as well as provide clinician and patient training and education about CGM and the Dexcom products.
AACE/ACE Consensus: Glucose Monitoring, Endocr Pract. 2015;21(No. 5) 523-530.
JDRF Continuous Glucose Monitoring Study Group. N Engl J Med. 2008;359(14):1464-1476.
* To view a list of compatible devices, visit www.dexcom.com/compatibility
LBL014047 Rev 001